
Robert Jenkins
Examiner (ID: 15672)
| Most Active Art Unit | 2402 |
| Art Unit(s) | 1726, 3405, 2899, 1302, 2402 |
| Total Applications | 1932 |
| Issued Applications | 1833 |
| Pending Applications | 19 |
| Abandoned Applications | 80 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13777781
[patent_doc_number] => 20190002429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => Derivatives of Xanthone Compounds
[patent_app_type] => utility
[patent_app_number] => 15/934253
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15934253
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/934253 | Derivatives of Xanthone Compounds | Mar 22, 2018 | Abandoned |
Array
(
[id] => 15191307
[patent_doc_number] => 10493124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Angiotensin II alone or in combination for the treatment of hypotension
[patent_app_type] => utility
[patent_app_number] => 15/909617
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10289
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15909617
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/909617 | Angiotensin II alone or in combination for the treatment of hypotension | Feb 28, 2018 | Issued |
Array
(
[id] => 12884851
[patent_doc_number] => 20180186792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => HETEROBIFUNCTIONAL LINKERS WITH POLYETHYLENE GLYCOL SEGMENTS AND IMMUNE RESPONSE MODIFIER CONJUGATES MADE THEREFROM
[patent_app_type] => utility
[patent_app_number] => 15/905367
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16331
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15905367
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/905367 | Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom | Feb 25, 2018 | Issued |
Array
(
[id] => 16041137
[patent_doc_number] => 10682419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Prodrugs of peptide epoxy ketone protease inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/881919
[patent_app_country] => US
[patent_app_date] => 2018-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 46
[patent_no_of_words] => 49362
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 421
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15881919
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/881919 | Prodrugs of peptide epoxy ketone protease inhibitors | Jan 28, 2018 | Issued |
Array
(
[id] => 12786367
[patent_doc_number] => 20180153958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => CYCLIC DEPSIPEPTIDE COMPOUNDS AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 15/882510
[patent_app_country] => US
[patent_app_date] => 2018-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15882510
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/882510 | CYCLIC DEPSIPEPTIDE COMPOUNDS AND THEIR USES | Jan 28, 2018 | Abandoned |
Array
(
[id] => 13328509
[patent_doc_number] => 20180215792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => TWO-DIMENSIONAL STRUCTURES FROM PEPTOID OLIGOMERS AND METHODS OF MAKING
[patent_app_type] => utility
[patent_app_number] => 15/880768
[patent_app_country] => US
[patent_app_date] => 2018-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15880768
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/880768 | TWO-DIMENSIONAL STRUCTURES FROM PEPTOID OLIGOMERS AND METHODS OF MAKING | Jan 25, 2018 | Abandoned |
Array
(
[id] => 12808861
[patent_doc_number] => 20180161457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => DISULFIDE-LINKED POLYETHYLENEGLYCOL/PEPTIDE CONJUGATES FOR THE TRANSFECTION OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 15/874338
[patent_app_country] => US
[patent_app_date] => 2018-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 281
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15874338
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/874338 | Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids | Jan 17, 2018 | Issued |
Array
(
[id] => 12706909
[patent_doc_number] => 20180127469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => SUBSTITUTED UREA DEPSIPEPTIDE ANALOGS AS ACTIVATORS OF THE CLPP ENDOPEPTIDASE
[patent_app_type] => utility
[patent_app_number] => 15/863673
[patent_app_country] => US
[patent_app_date] => 2018-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 442
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15863673
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/863673 | Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase | Jan 4, 2018 | Issued |
Array
(
[id] => 13300233
[patent_doc_number] => 20180201653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => POLYPEPTIDE COMPOUND AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/852288
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15852288
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/852288 | Polypeptide compound and preparation method and use thereof | Dec 21, 2017 | Issued |
Array
(
[id] => 12863137
[patent_doc_number] => 20180179553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => COMPOSITIONS AND METHODS FOR NUCLEIC ACID AND/OR PROTEIN PAYLOAD DELIVERY
[patent_app_type] => utility
[patent_app_number] => 15/842829
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15842829
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/842829 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID AND/OR PROTEIN PAYLOAD DELIVERY | Dec 13, 2017 | Abandoned |
Array
(
[id] => 12606603
[patent_doc_number] => 20180094031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => CYCLOSPORIN DERIVATIVES WHEREIN THE MEBMT SIDECHAIN HAS BEEN CYCLIZED
[patent_app_type] => utility
[patent_app_number] => 15/831681
[patent_app_country] => US
[patent_app_date] => 2017-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15831681
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/831681 | CYCLOSPORIN DERIVATIVES WHEREIN THE MEBMT SIDECHAIN HAS BEEN CYCLIZED | Dec 4, 2017 | Abandoned |
Array
(
[id] => 12790690
[patent_doc_number] => 20180155399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => TFPI INHIBITORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/815347
[patent_app_country] => US
[patent_app_date] => 2017-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15815347
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/815347 | TFPI inhibitors and methods of use | Nov 15, 2017 | Issued |
Array
(
[id] => 12233174
[patent_doc_number] => 20180066032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS'
[patent_app_type] => utility
[patent_app_number] => 15/815644
[patent_app_country] => US
[patent_app_date] => 2017-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 106128
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15815644
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/815644 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | Nov 15, 2017 | Abandoned |
Array
(
[id] => 15225001
[patent_doc_number] => 10500204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Vitamin receptor drug delivery conjugates for treating inflammation
[patent_app_type] => utility
[patent_app_number] => 15/811600
[patent_app_country] => US
[patent_app_date] => 2017-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 81
[patent_figures_cnt] => 119
[patent_no_of_words] => 33915
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15811600
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/811600 | Vitamin receptor drug delivery conjugates for treating inflammation | Nov 12, 2017 | Issued |
Array
(
[id] => 16230798
[patent_doc_number] => 10738338
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
[patent_app_type] => utility
[patent_app_number] => 15/782391
[patent_app_country] => US
[patent_app_date] => 2017-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 13784
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15782391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/782391 | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate | Oct 11, 2017 | Issued |
Array
(
[id] => 14497913
[patent_doc_number] => 20190192611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => COMPOSITION FOR TREATING CELLULITE, AND MICRO-NEEDLE INCLUDING SAME
[patent_app_type] => utility
[patent_app_number] => 16/329553
[patent_app_country] => US
[patent_app_date] => 2017-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329553
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/329553 | Composition for treating cellulite, and microneedle including same | Aug 28, 2017 | Issued |
Array
(
[id] => 12158827
[patent_doc_number] => 20180030094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'CHEMICAL SYNTHESIS AND SCREENING OF BICYCLIC PEPTIDE LIBRARIES'
[patent_app_type] => utility
[patent_app_number] => 15/672617
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 38634
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672617
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/672617 | Chemical synthesis and screening of bicyclic peptide libraries | Aug 8, 2017 | Issued |
Array
(
[id] => 12058621
[patent_doc_number] => 20170334965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'SFRP5-DERIVED PEPTIDE FRAGMENT AND COSMETIC COMPOSITION FOR SKIN WHITENING CONTAINING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/664277
[patent_app_country] => US
[patent_app_date] => 2017-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3790
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15664277
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/664277 | SFRP5-derived peptide fragment and cosmetic composition for skin whitening containing same | Jul 30, 2017 | Issued |
Array
(
[id] => 12706900
[patent_doc_number] => 20180127466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => NMDA RECEPTOR MODULATORS AND PRODRUGS, SALTS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/658107
[patent_app_country] => US
[patent_app_date] => 2017-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15658107
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/658107 | NMDA receptor modulators and prodrugs, salts, and uses thereof | Jul 23, 2017 | Issued |
Array
(
[id] => 14452489
[patent_doc_number] => 10322191
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => Targeted conjugates and particles and formulations thereof
[patent_app_type] => utility
[patent_app_number] => 15/652957
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 42043
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15652957
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/652957 | Targeted conjugates and particles and formulations thereof | Jul 17, 2017 | Issued |